Stem Cell Therapeutic Outcomes Database

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
07192024 - Current SCTOD Information Collections - Fall 2024.xlsx	Justification for No Material/Nonsubstantive Change	Uploaded 2024-07-24	Available
07192024 - OMB Non-Substantive Change Request - SCTOD - Fall 2024 - CLEAN.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2024-07-24	Available
HSB-SCOTD- NSC Change Memo- 0915-0310- 05.14.2024.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2024-05-14	Available
HSB-SCOTD Collection- Current SCTOD Information Collection- 5.10.2024.xlsx	Supplementary Document	Uploaded 2024-05-14	Available
MASTER_Current SCTOD Information Collections-Spring 2024_to HRSA 2024-04-08.xlsx	Justification for No Material/Nonsubstantive Change	Uploaded 2024-04-08	Repair queued
SCTOD_OMB NonSubstantive Change Request Spring 2024_to HRSA 2024-04-08.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2024-04-08	Available
02062024 - Current SCTOD Information Collections to HRSA - 020620245001.xlsx	Justification for No Material/Nonsubstantive Change	Uploaded 2024-02-06	Available
02062024 - Memo to OMB - SCTOD OMB Non-Substantive Change Request - CLEAN.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2024-02-06	Available
08142023 - Tab B - Current SCTOD Information Collections to HRSA - 081420235006.xlsx	Supplementary Document	Uploaded 2023-09-20	Available
08142023 - Tab A - Published FRN 2022-12225 Highlighted - 081420235006.PDF	Supplementary Document	Uploaded 2023-09-20	Available
08182023 - SCTOD Non-Substantive Change Memo - OMB 0915-0310 - 081420235006.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2023-09-20	Available
01262023 - Attachment 1 - Current SCTOD Information Collections - Incremental Changes.xlsx	Justification for No Material/Nonsubstantive Change	Uploaded 2023-02-08	Available
01262023 - Change Memo - SCTOD Collection - OMB 0915-0310.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2023-02-08	Available
Supporting Statement _ SCTOD _ CLEAN 7.13.2022.docx	Supporting Statement A	Uploaded 2022-07-13	Available
6 - Change Summary_to HRSA 2022-03-29.pdf	Supplementary Document	Uploaded 2022-07-13	Available
5e - Information Collection Domain_Pre-Transplant Information Collection _SCTOD.xlsx	Supplementary Document	Uploaded 2022-07-13	Available
5d - Header Definitions_to HRSA 2022-03-29.pdf	Supplementary Document	Uploaded 2022-07-13	Available
5c - Post-Transplant Info Collection_to HRSA 2022-03-29.pdf	Supplementary Document	Uploaded 2022-07-13	Available
5b - Product Procedure Info Collection_to HRSA 2022-03-29.pdf	Supplementary Document	Uploaded 2022-07-13	Available
5a - Pre-Transplant Info Collection_to HRSA 2022-03-29.pdf	Supplementary Document	Uploaded 2022-07-13	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
254631	Post-Transplant Periodic Information Collection based on Predetermined Schedule	Other-Information to Private Sector	Unchanged
254630	Transplant Procedure and Product Information	Other-Information for Private Entites	Unchanged
254628	Pre-Transplant Information Collection	Other-Information to Private Sector	Modified

ICR Details

OMB Control No: 0915-0310	ICR Reference No: 202407-0915-001
Status: Active	Previous ICR Reference No: 202405-0915-001
Agency/Subagency: HHS/HSA	Agency Tracking No: 21065
Title: Stem Cell Therapeutic Outcomes Database
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/25/2024
	Date Received in OIRA: 07/25/2024
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2025	08/31/2025	08/31/2025
Responses	75,101	0	75,101
Time Burden (Hours)	75,101	0	75,101
Cost Burden (Dollars)	0	0	0

---

Abstract: The Stem Cell Therapeutic Outcomes Database was established under contract by HRSA to establish and maintain information related to patients who have received stem cell therapeutic products using a standardized, electronic format. Data is collected from transplant centers by the Center for International Blood and Marrow Transplant Research and is used for ongoing analysis of transplant outcomes. HRSA uses the information to carry out its statutory responsibilities. Information is needed to monitor the clinical status of transplantation and to provide the Secretary of HHS with an annual report of transplant center-specific survival data.

---

Authorizing Statute(s): US Code: 42 USC 24K, section 379 Name of Law: TRANSPLANT Act of 2021
   PL: Pub.L. 111 - 148 0 Name of Law: TRANSPLANT Act of 2021’’
   PL: Pub.L. 109 - 129 0 Name of Law: The Stem Cell Therapeutic and Research Reauthorization Act of 2010
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 15439	03/18/2022
30-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 34692	06/07/2022
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 3

table that charts list of burden

IC Title	Form No.	Form Name
Post-Transplant Periodic Information Collection based on Predetermined Schedule
Pre-Transplant Information Collection
Transplant Procedure and Product Information

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	75,101	75,101	0	0	0	0
Annual Time Burden (Hours)	75,101	75,101	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $4,730,240

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/25/2024

---